Arrowhead Pharmaceuticals (NASDAQ: ARWR) Price Target Raised Amid Strong Plozasiran Trial Results

显示全文

该功能仅适用于授权用户

• 债券全称
  Arrowhead Pharmaceuticals, Inc.
• 注册地国家
  USA
• 行业
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***